 |
|
|
| |
Identifying and Prioritizing Hepatitis C Treatment for HIV-Hepatitis C Co-Infection
|
| |
| |
71% of co-infected patients met IDSA/AASLD/IAS-USA priority treatment criteria (47% had fibrosis, 22% advanced fibrosis/compensated cirrhosis (F3/F4) with an additional 16% meeting treatment criteria due to elated transmission risk (Table 2)
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Castel AD, KalminMM, Hart RLD, Greenberg AE, MasurH, on Behalf of the DC Cohort Executive Committee
George Washington University, Milken Institute School of Public Health
|
| |
|
|
|
|
|
